Notably, preclinical data - including those discussed in this mini-review - indicate that Hsp90 contributes to AD pathophysiology at multiple levels: from modulating T cell differentiation and cytokine production to regulating keratinocyte stress responses and skin–microbiota interactions. Here, HSP90AA1 is linked to Alzheimer disease.